Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.23 CHF | +0.80% | -1.66% | +7.49% |
02:35pm | Goldman Sachs Starts Novartis With Buy Rating, $120 Price Target | MT |
10:09am | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.49% | 202B | |
+39.66% | 731B | |
+31.34% | 586B | |
-7.38% | 348B | |
+16.60% | 319B | |
+0.41% | 273B | |
+13.47% | 235B | |
-6.63% | 203B | |
+3.73% | 159B | |
-2.93% | 158B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Morgan Stanley Lifts Price Target on Novartis, Maintains Equalweight/In-Line Recommendation